Impairment loss on goodwill (Details Narrative) |
2 Months Ended | |||
|---|---|---|---|---|
|
Jun. 30, 2025
SGD ($)
|
Oct. 31, 2025
USD ($)
|
Apr. 30, 2025
USD ($)
|
Apr. 30, 2025
SGD ($)
|
|
| IfrsStatementLineItems [Line Items] | ||||
| Consideration transferred | $ 10,339,950 | |||
| Revenue of acquiree since acquisition date | $ 895,362 | |||
| Net profit | $ 206,629 | |||
| Purchase consideration | $ 8,000,000 | |||
| Deferred cash consideration | $ 1,500,000 | |||
| Bethesda Medical Pte Ltd [Member] | ||||
| IfrsStatementLineItems [Line Items] | ||||
| Consideration transferred | $ 8,000,000 | $ 10,339,950 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The fair value, at acquisition date, of other tangible or intangible assets (including a business or subsidiary of the acquirer) transferred as consideration in a business combination, that the entity does not separately disclose in the same note. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]; Total for all subsidiaries [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|